ALK-Abelló A/S ALK-B.CO Stock
ALK-Abelló A/S Price Chart
ALK-Abelló A/S ALK-B.CO Financial and Trading Overview
| ALK-Abelló A/S stock price | 124.6 DKK |
| Previous Close | 86.5 DKK |
| Open | 87.05 DKK |
| Bid | 87.85 DKK x 0 |
| Ask | 87.8 DKK x 0 |
| Day's Range | 86.95 - 88.25 DKK |
| 52 Week Range | 80.75 - 156.2 DKK |
| Volume | 79.75K DKK |
| Avg. Volume | 604.99K DKK |
| Market Cap | 19.53B DKK |
| Beta (5Y Monthly) | 0.381992 |
| PE Ratio (TTM) | 58.112583 |
| EPS (TTM) | 2.21 DKK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | March 16, 2017 |
| 1y Target Est | 136.83 DKK |
ALK-B.CO Valuation Measures
| Enterprise Value | 19.88B DKK |
| Trailing P/E | 58.112583 |
| Forward P/E | 24.579832 |
| PEG Ratio (5 yr expected) | 0.32 |
| Price/Sales (ttm) | 4.25404 |
| Price/Book (mrq) | 4.713181 |
| Enterprise Value/Revenue | 4.331 |
| Enterprise Value/EBITDA | 29.321 |
Trading Information
ALK-Abelló A/S Stock Price History
| Beta (5Y Monthly) | 0.381992 |
| 52-Week Change | -24.84% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 156.2 DKK |
| 52 Week Low | 80.75 DKK |
| 50-Day Moving Average | 90.35 DKK |
| 200-Day Moving Average | 105.63 DKK |
ALK-B.CO Share Statistics
| Avg. Volume (3 month) | 604.99K DKK |
| Avg. Daily Volume (10-Days) | 439K DKK |
| Shares Outstanding | 200.74M |
| Float | 131.38M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 61.08% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 20:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 7.29% |
| Operating Margin (ttm) | 11.19% |
| Gross Margin | 62.78% |
| EBITDA Margin | 14.77% |
Management Effectiveness
| Return on Assets (ttm) | 5.21% |
| Return on Equity (ttm) | 8.61% |
Income Statement
| Revenue (ttm) | 4.59B DKK |
| Revenue Per Share (ttm) | 20.82 DKK |
| Quarterly Revenue Growth (yoy) | 6.80% |
| Gross Profit (ttm) | 2.82B DKK |
| EBITDA | 678M DKK |
| Net Income Avi to Common (ttm) | 335M DKK |
| Diluted EPS (ttm) | 1.51 |
| Quarterly Earnings Growth (yoy) | 0% |
Balance Sheet
| Total Cash (mrq) | 191M DKK |
| Total Cash Per Share (mrq) | 0.86 DKK |
| Total Debt (mrq) | 639M DKK |
| Total Debt/Equity (mrq) | 15.52 DKK |
| Current Ratio (mrq) | 2.014 |
| Book Value Per Share (mrq) | 18.618 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 479M DKK |
| Levered Free Cash Flow (ttm) | 45.38M DKK |
Profile of ALK-Abelló A/S
| Country | Denmark |
| State | N/A |
| City | Horsholm |
| Address | Boge Alle 6-8 |
| ZIP | 2970 |
| Phone | 45 45 74 75 76 |
| Website | https://www.alk.net |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2712 |
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. It product portfolio include GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food. It also provides consumer healthcare solution, which include Digital eco-system, a platform which connect and engages with allergy sufferers much earlier in the disease journey through tools and e-commerce offerings that supports, guidance and relief, and smoothing the path to allergy immunotherapy treatment. In addition, the company offers diagnostic allergy solutions through testing by skin prick test or blood test; and emergency treatment, such as intramuscular injection of adrenaline for the treatment of acute life-threatening allergic reactions including Anaphylaxis. ALK-Abelló A/S was founded in 1923 and is headquartered in Hørsholm, Denmark.
Q&A For ALK-Abelló A/S Stock
What is a current ALK-B.CO stock price?
ALK-Abelló A/S ALK-B.CO stock price today per share is 124.6 DKK.
How to purchase ALK-Abelló A/S stock?
You can buy ALK-B.CO shares on the Copenhagen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ALK-Abelló A/S?
The stock symbol or ticker of ALK-Abelló A/S is ALK-B.CO.
Which industry does the ALK-Abelló A/S company belong to?
The ALK-Abelló A/S industry is Biotechnology.
How many shares does ALK-Abelló A/S have in circulation?
The max supply of ALK-Abelló A/S shares is 221.19M.
What is ALK-Abelló A/S Price to Earnings Ratio (PE Ratio)?
ALK-Abelló A/S PE Ratio is 56.38009000 now.
What was ALK-Abelló A/S earnings per share over the trailing 12 months (TTM)?
ALK-Abelló A/S EPS is 2.21 DKK over the trailing 12 months.
Which sector does the ALK-Abelló A/S company belong to?
The ALK-Abelló A/S sector is Healthcare.
ALK-Abelló A/S ALK-B.CO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| OMX_Nordic_Large_Cap_SEK_GI OMXNLCSEKGI | 529.96 SEK 51.73 USD |
+0.39
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Large_Cap_EUR_GI OMXNLCEURGI | 424.25 EUR 463.76 USD |
-0.11
|
— — | — — | — — | — - | — — |
| OMX Copenhagen Ex OMXC20 Index OMXCXC20PI | 8216.95 DKK 1204.78 USD |
-0.79
|
— — | — — | — — | — - | — — |
| OMX Copenhagen_PI OMXCPI | 1847.14 DKK 270.83 USD |
+0.38
|
— — | — — | — — | — - | — — |
| OMX Copenhagen_GI OMXCGI | 3465.57 DKK 508.13 USD |
+0.39
|
— — | — — | — — | — - | — — |
| OMX Copenhagen Cap_GI OMXCCAPGI | 2771.14 DKK 406.31 USD |
-0.58
|
— — | — — | — — | — - | — — |
| OMX Copenhagen Health Care PI CX20PI | 9589.29 DKK 1405.99 USD |
+0.61
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Large_Cap_ISK_GI OMXNLCISKGI | 613.85 ISK 4.51 USD |
-0.11
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Large_Cap_DKK_GI OMXNLCDKKGI | 424.43 DKK 62.23 USD |
-0.09
|
— — | — — | — — | — - | — — |
| OMX Copenhagen Ex OMXC20 Index OMXCXC20GI | 15026.17 DKK 2203.15 USD |
-0.79
|
— — | — — | — — | — - | — — |
| OMX_Copenhagen_Large_Cap_PI OMXCLCPI | 561.78 DKK 82.37 USD |
+0.4
|
— — | — — | — — | — - | — — |
| OMX Copenhagen Cap_PI OMXCCAPPI | 1455.94 DKK 213.47 USD |
-0.6
|
— — | — — | — — | — - | — — |
| NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
| OMX Copenhagen Pharmaceuticals CX201030PI | 10605.7 DKK 1555.02 USD |
+1.02
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}